Log in to save to my catalogue

Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 i...

Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 i...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_11e7d2592b6245868d62b286966a8ec3

Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series

About this item

Full title

Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series

Publisher

England: BioMed Central

Journal title

BMC infectious diseases, 2019-10, Vol.19 (1), p.858-858, Article 858

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Intravenous (IV) zanamivir could be a suitable alternative for the treatment of severe influenza A(H1N1)pdm09 infection in patients who are unable to take oral or inhaled medication, for example, those on mechanical ventilation and extracorporeal membrane oxygenation (ECMO). However, data on the clinical outcomes of such patients is limited.
We...

Alternative Titles

Full title

Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_11e7d2592b6245868d62b286966a8ec3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_11e7d2592b6245868d62b286966a8ec3

Other Identifiers

ISSN

1471-2334

E-ISSN

1471-2334

DOI

10.1186/s12879-019-4530-1

How to access this item